These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23273775)

  • 21. [Mechanism of methamphetamine intoxication and its medical identification].
    Gao WM; Wan Y; Mao RM; Mi L; Du ZB; Cao ZP; Zhu BL
    Fa Yi Xue Za Zhi; 2012 Apr; 28(2):126-9. PubMed ID: 22619810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine-induced neural and cognitive changes in rodents.
    Marshall JF; Belcher AM; Feinstein EM; O'Dell SJ
    Addiction; 2007 Apr; 102 Suppl 1():61-9. PubMed ID: 17493054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.
    Shrestha P; Katila N; Lee S; Seo JH; Jeong JH; Yook S
    Biomed Pharmacother; 2022 Oct; 154():113591. PubMed ID: 36007276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meth mouth: methamphetamine and oral health.
    Padilla R; Ritter AV
    J Esthet Restor Dent; 2008; 20(2):148-9. PubMed ID: 18380848
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why is parkinsonism not a feature of human methamphetamine users?
    Moszczynska A; Fitzmaurice P; Ang L; Kalasinsky KS; Schmunk GA; Peretti FJ; Aiken SS; Wickham DJ; Kish SJ
    Brain; 2004 Feb; 127(Pt 2):363-70. PubMed ID: 14645148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?
    Sullivan D; McDonough Michael
    J Law Med; 2015 Sep; 23(1):41-9. PubMed ID: 26554196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
    Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers.
    Hosak L; Preiss M; Bazant J; Tibenska A; Cermakova R; Cermakova E
    Psychiatr Danub; 2012 Jun; 24(2):188-93. PubMed ID: 22706418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.
    Courtney KE; Ray LA
    Drug Alcohol Depend; 2014 Oct; 143():11-21. PubMed ID: 25176528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of methamphetamine and amphetamine in drug abusers' head hair.
    Lee S; Han E; Park Y; Choi H; Chung H
    Forensic Sci Int; 2009 Sep; 190(1-3):16-8. PubMed ID: 19501481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.